Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Medication can effectively reduce hair growth and improve life quality for women with hirsutism.

People with polycystic ovary syndrome often have low levels of vitamin D.

Hair analysis shows low progesterone in anorexia patients, unchanged by short-term weight gain.

PCOS is a common hormonal disorder in women that can affect skin, fertility, and metabolism, and treatment is tailored to individual needs.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Women with irregular periods have a higher risk of heart disease.

Many acne patients have high androgen levels, which may lead to PCOD, but treatments like oral contraceptives and antiandrogens can help.

Women with PCOS have significant metabolic issues like insulin resistance after eating a high-fat meal.

Women with acne and irregular periods had higher active testosterone levels, which could suggest the usefulness of antiandrogen treatment.

Most women with hirsutism have mild symptoms and often experience acne, menstrual irregularities, and obesity.

Properly monitored hormone therapy can improve life quality, but misuse can cause serious health issues.

Statins significantly reduce testosterone and improve skin symptoms in women with PCOS.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Hirsutism in teen girls is common, usually harmless, but can sometimes signal serious issues and is treatable.

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Acne in adult women may occur alone or with signs of high male hormones.

Idiopathic hirsutism may be linked to increased enzyme activity.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Vietnamese women with PCOS tend to be younger, have larger waists, higher AMH levels, and more body hair than those without PCOS.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Oral contraceptives and antiandrogens are effective for treating hirsutism, with antiandrogens being the most effective.

A rare ovarian tumor caused high testosterone, hair loss, and missed periods, but surgery fixed these issues and led to pregnancy.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Different types of polycystic ovary syndrome show varying levels of insulin resistance, with the 'PHO' type being the most insulin resistant.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.